港股生物医药股盘初走高，映恩生物大涨超13%

Group 1 - Hong Kong biopharmaceutical stocks experienced an initial rise on September 8, with major gains observed in several companies [1] - In particular, InnoCare Pharma surged over 13% after being included in the Hang Seng Composite Index [1] - Other notable performers included Junshi Biosciences and WuXi Biologics, which saw increases of over 3% [1]